Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 2/20 | 0.31 |
| ▸ | CTH | P32929 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28968781 | 0.87 | TLR2 (0.31) | TLR2CTHGLAL3MBTL1MEN1 | |
| SCHEMBL28615705 | 0.85 | TLR2 (0.33) | TLR2CYP1A2KMT2ALMNA | |
| SCHEMBL3208469 | 0.84 | CYP3A4 (0.34) | MEN1CYP1A2KMT2ALMNA | |
| SCHEMBL28377447 | 0.83 | ALDH1A1 (0.32) | GLAL3MBTL1 | |
| SCHEMBL28615703 | 0.82 | TLR2 (0.33) | TLR2CYP1A2KMT2ALMNA | |
| SCHEMBL21405225 | 0.80 | GLA (0.37) | CTHGLAL3MBTL1 | |
| SCHEMBL28933423 | 0.80 | CYP3A4 (0.32) | — | |
| SCHEMBL12997234 | 0.80 | CYP3A4 (0.32) | — | |
| SCHEMBL12997235 | 0.80 | CYP3A4 (0.32) | — | |
| SCHEMBL28553600 | 0.77 | ALDH1A1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115968296-A | C-type natriuretic peptides and methods of treating cancer therewith | 药明公司 | 2023-04-14 | — | — | CN | claimed |
| CN-115803338-A | C-type natriuretic peptide and method for treating acute lung injury | 药明公司 | 2023-03-14 | — | — | CN | claimed |
| CN-115968296-A | C-type natriuretic peptides and methods of treating cancer therewith | 药明公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-115803338-A | C-type natriuretic peptide and method for treating acute lung injury | 药明公司 | 2023-03-14 | — | — | CN | disclosed |